Speech apraxia
Gene: SHANK3
First reported CAS case with a de novo SHANK3 frameshift variant (Kaspi et al., 2022; PMID: 36117209).
Brignell et al. (2021; PMID: 33293697) report 2 cases of CAS in a cohort of individuals with Phelan-McDermid/22q13 deletion syndrome, caused by heterozygous loss of function of SHANK3.
Sources: Expert list, Expert ReviewCreated: 28 Jun 2024, 5:52 a.m. | Last Modified: 1 Jul 2024, 11:11 a.m.
Panel Version: 0.38
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Phelan-McDermid syndrome, MIM# 606232
Publications
Gene: shank3 has been classified as Amber List (Moderate Evidence).
Gene: shank3 has been classified as Green List (High Evidence).
Gene: shank3 has been classified as Green List (High Evidence).
gene: SHANK3 was added gene: SHANK3 was added to Speech apraxia. Sources: Expert list,Expert Review Mode of inheritance for gene: SHANK3 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: SHANK3 were set to 36117209; 33293697 Phenotypes for gene: SHANK3 were set to Phelan-McDermid syndrome, MIM# 606232 Review for gene: SHANK3 was set to GREEN